B

Basilea Pharmaceutica AG Allschwil
SWB:PK5

Watchlist Manager
Basilea Pharmaceutica AG Allschwil
SWB:PK5
Watchlist
Price: 57.4 EUR -0.35% Market Closed
Market Cap: 692.9m EUR

Intrinsic Value

The intrinsic value of one PK5 stock under the Base Case scenario is hidden EUR. Compared to the current market price of 57.4 EUR, Basilea Pharmaceutica AG Allschwil is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

PK5 Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
Basilea Pharmaceutica AG Allschwil

Intrinsic Value History
Dive into the past to invest in the future

PK5 looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether PK5 usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about PK5?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PK5 valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Basilea Pharmaceutica AG Allschwil.

Explain Valuation
Compare PK5 to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Contacts
Loading...
How do you feel about PK5?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Basilea Pharmaceutica AG Allschwil

Current Assets 217.5m
Cash & Short-Term Investments 128.4m
Receivables 57.3m
Other Current Assets 31.8m
Non-Current Assets 31.4m
PP&E 17.5m
Intangibles 335k
Other Non-Current Assets 13.5m
Current Liabilities 34.4m
Accounts Payable 9.9m
Accrued Liabilities 19.4m
Other Current Liabilities 5.1m
Non-Current Liabilities 111.3m
Long-Term Debt 82m
Other Non-Current Liabilities 29.3m
Efficiency

Free Cash Flow Analysis
Basilea Pharmaceutica AG Allschwil

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Basilea Pharmaceutica AG Allschwil

Revenue
236.2m CHF
Cost of Revenue
-44.8m CHF
Gross Profit
191.4m CHF
Operating Expenses
-115.5m CHF
Operating Income
76m CHF
Other Expenses
-3.3m CHF
Net Income
72.7m CHF
Fundamental Scores

PK5 Profitability Score
Profitability Due Diligence

Basilea Pharmaceutica AG Allschwil's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional ROIC
Exceptional 3Y Average ROIC
Exceptional ROE
ROIC is Increasing
hidden
Profitability
Score

Basilea Pharmaceutica AG Allschwil's profitability score is hidden . The higher the profitability score, the more profitable the company is.

PK5 Solvency Score
Solvency Due Diligence

Basilea Pharmaceutica AG Allschwil's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Interest Coverage
Short-Term Solvency
Negative Net Debt
Long-Term Solvency
hidden
Solvency
Score

Basilea Pharmaceutica AG Allschwil's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PK5 Price Targets Summary
Basilea Pharmaceutica AG Allschwil

There are no price targets for PK5.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PK5 is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one PK5 stock?

The intrinsic value of one PK5 stock under the Base Case scenario is hidden EUR.

Is PK5 stock undervalued or overvalued?

Compared to the current market price of 57.4 EUR, Basilea Pharmaceutica AG Allschwil is hidden .

Back to Top